Abbonarsi

Repeat peroral endoscopic myotomy: technical difficulty and risk factors - 08/05/25

Doi : 10.1016/j.gie.2024.11.019 
Li-Yun Ma, MD , Ke-Yi Guo, MD , Zu-Qiang Liu, MD , Shi-Yao Chen, MD, Yun-Shi Zhong, MD, Yi-Qun Zhang, MD, Wei-Feng Chen, MD, Li-Li Ma, MD, Wen-Zheng Qin, MD, Jian-Wei Hu, MD, Ming-Yan Cai, MD, FASGE, Li-Qing Yao, MD, Quan-Lin Li, MD , Ping-Hong Zhou, MD, FASGE
 Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China 

Reprint requests: Ping-Hong Zhou, MD, FASGE, Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China.Endoscopy Center and Endoscopy Research InstituteShanghai Collaborative Innovation Center of EndoscopyZhongshan HospitalFudan UniversityShanghaiChinaQuan-Lin Li, MD, Endoscopy Center and Endoscopy Research Institute, Shanghai Collaborative Innovation Center of Endoscopy, Zhongshan Hospital, Fudan University, Shanghai, China.Endoscopy Center and Endoscopy Research InstituteShanghai Collaborative Innovation Center of EndoscopyZhongshan HospitalFudan UniversityShanghaiChina

Abstract

Background and Aims

Repeat peroral endoscopic myotomy (Re-POEM) appears to be a promising salvage option for patients with persistent or recurrent symptoms after initial POEM, but it may be more technically challenging. Here we aim to evaluate the safety and technical difficulty of Re-POEM.

Methods

Between July 2012 and October 2023, 158 achalasia patients underwent Re-POEM and were retrospectively enrolled. Another 2978 patients without prior myotomy were selected for the naïve POEM group. After propensity score matching (PSM), procedure-related parameters were compared between the 2 groups. Univariable and multivariable analyses were performed to reveal risk factors for difficult Re-POEM (defined as procedure time ≥90 minutes).

Results

With similar baseline characteristics between the 2 groups after PSM, the procedure time was comparable between Re-POEM and naïve POEM groups (61.4 ± 27.0 vs 59.3 ± 29.9, P = .496). The Re-POEM group had a shorter esophageal myotomy length (7.0 ± 2.1 cm vs 8.2 ± 1.1 cm, P < .001) and longer gastric myotomy length (2.3 ± .6 cm vs 2.1 ± .4 cm, P = .017) compared with the naïve POEM group. Mucosal injury in the Re-POEM group was slightly higher, which was not statistically significant (20.3% vs 13.9%, P = .135). No differences were found in the incidence of gas-related adverse events (AEs), major AEs, and technical difficulty. Multivariate analysis determined mucosal edema (odds ratio, 4.942; 95% confidence interval, 1.554-15.714; P = .007) and submucosal fibrosis (odds ratio, 3.817; 95% confidence interval, 1.333-10.931; P = .013) to be independent risk factors for difficult Re-POEM.

Conclusions

Re-POEM appears to be safe and feasible as a salvage option after initial POEM failure, with comparable procedure duration, incidence of AEs, and technical difficulty with naïve POEM. Mucosal edema and submucosal fibrosis were associated with difficult Re-POEM.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : AE, CI, EGJ, LES, OR, POEM, PSM, Re-POEM


Mappa


© 2025  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 101 - N° 6

P. 1120 - giugno 2025 Ritorno al numero
Articolo precedente Articolo precedente
  • Avoiding additional adverse events: exercising caution with use of transpapillary covered metal biliary stents
  • Stuart K. Amateau
| Articolo seguente Articolo seguente
  • Validation of British Society of Gastroenterology guidelines for acute lower GI bleeding from 8956 cases in Japan
  • Ken Kinjo, Tomonori Aoki, Katsumasa Kobayashi, Atsushi Yamauchi, Atsuo Yamada, Jun Omori, Takashi Ikeya, Taiki Aoyama, Naoyuki Tominaga, Yoshinori Sato, Takaaki Kishino, Naoki Ishii, Tsunaki Sawada, Masaki Murata, Akinari Takao, Kazuhiro Mizukami, Shunji Fujimori, Takahiro Uotani, Minoru Fujita, Hiroki Sato, Sho Suzuki, Toshiaki Narasaka, Junnosuke Hayasaka, Tomohiro Funabiki, Yuzuru Kinjo, Akira Mizuki, Shu Kiyotoki, Tatsuya Mikami, Ryosuke Gushima, Hiroyuki Fujii, Yuta Fuyuno, Takuto Hikichi, Yosuke Toya, Kazuyuki Narimatsu, Noriaki Manabe, Koji Nagaike, Tetsu Kinjo, Yorinobu Sumida, Sadahiro Funakoshi, Kiyonori Kobayashi, Tamotsu Matsuhashi, Yuga Komaki, Kazuhiro Watanabe, Takashi Hisabe, Kenshi Yao, Mitsuru Kaise, Naoyoshi Nagata

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.